Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 7, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Removing reprogramming roadblocks: Mbd3 depletion allows deterministic iPSC generation.

Justin Brumbaugh1, Konrad Hochedlinger

  • 1Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA.

Cell Stem Cell
|October 8, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Cleavage of histone H2A during embryonic stem cell differentiation destabilizes nucleosomes to counteract gene activation.

The Journal of biological chemistry·2026
Same author

Feeder-free yet still naïve: improved method for capturing human pluripotent stem cells.

The EMBO journal·2026
Same author

Post-replicative chromatin accessibility predicts cell fate change.

Stem cell reports·2026
Same author

Morphomechanic tuning of ERK by actin-TFII-IΔ regulates cell identity.

bioRxiv : the preprint server for biology·2026
Same author

Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regeneration.

Nature communications·2026
Same journal

Psychological stress drives aging-like hematopoietic stem cell dysfunction through a brain-gut-bone marrow axis.

Cell stem cell·2026
Same journal

Human stem cell-based embryo model governance: Insights from Japan.

Cell stem cell·2026
Same journal

From reconstruction to intervention: Engineered organoids as living therapeutic depots.

Cell stem cell·2026
Same journal

Long-term lessons from MATCH01 macrophage therapy in cirrhosis.

Cell stem cell·2026
Same journal

Beyond apoptosis: LSC state dictates metabolic and anti-apoptotic vulnerabilities.

Cell stem cell·2026
Same journal

Outside the niche: Gut microbiota relay psychological stress to hematopoietic stem cell dysfunction.

Cell stem cell·2026
See all related articles

Eliminating methyl-binding protein 3 dramatically improves induced pluripotency, making this stem cell reprogramming process highly efficient and deterministic. This finding revolutionizes our understanding of cellular reprogramming.

Area of Science:

  • Stem cell biology
  • Epigenetics
  • Molecular biology

Background:

  • Transcription factor-induced pluripotency is a key technology for generating induced pluripotent stem cells.
  • Current methods for induced pluripotency are inefficient and highly stochastic, limiting their clinical applications.

Purpose of the Study:

  • To investigate novel strategies for enhancing the efficiency and determinism of induced pluripotency.
  • To identify specific molecular targets that can overcome the inherent stochasticity of cellular reprogramming.

Main Methods:

  • The study utilized a high-throughput screening approach to identify genes that modulate reprogramming efficiency.
  • CRISPR-Cas9 gene editing was employed to deplete specific genes, including methyl-binding protein 3.
  • Quantitative PCR and immunofluorescence were used to assess pluripotency markers and reprogramming outcomes.

More Related Videos

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

Related Experiment Videos

Last Updated: May 7, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

Main Results:

  • Depletion of methyl-binding protein 3 (MBD3) resulted in reprogramming efficiencies approaching 100% within days.
  • MBD3-deficient cells exhibited rapid acquisition of pluripotency markers.
  • The reprogramming process in MBD3-depleted cells was no longer stochastic but deterministic.

Conclusions:

  • Methyl-binding protein 3 is a critical barrier to efficient and deterministic induced pluripotency.
  • Eliminating MBD3 is sufficient to achieve near-complete reprogramming, offering a significant advancement in stem cell technology.
  • This discovery paves the way for more robust and predictable stem cell generation for research and therapeutic purposes.